{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:59:01Z","timestamp":1756461541201},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11596-010-0557-7","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T12:15:58Z","timestamp":1289304958000},"page":"643-647","source":"Crossref","is-referenced-by-count":8,"title":["Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Jiangtao","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"issue":"9176","key":"557_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"G.J. Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet, 1999,354(9176):407\u2013413","journal-title":"Lancet"},{"issue":"5","key":"557_CR2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/labinvest.3780275","volume":"81","author":"P. Durand","year":"2001","unstructured":"Durand P, Prost M, Loreau N, et al. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest, 2001,81(5):645\u2013672","journal-title":"Lab Invest"},{"issue":"1","key":"557_CR3","first-page":"111","volume":"56","author":"K.S. McCully","year":"1969","unstructured":"McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. The Am J of Pathol, 1969,56(1):111\u2013128","journal-title":"The Am J of Pathol"},{"issue":"2","key":"557_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","volume":"35","author":"F.M. Faraci","year":"2004","unstructured":"Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke, 2004, 35(2):345\u2013347","journal-title":"Stroke"},{"issue":"5","key":"557_CR5","first-page":"799","volume":"88","author":"G.H. Tofler","year":"2002","unstructured":"Tofler GH, D\u2019Agostino RB, Jacques PF, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb Haemost, 2002,88(5): 799\u2013804","journal-title":"Thromb Haemost"},{"issue":"38","key":"557_CR6","doi-asserted-by":"crossref","first-page":"35867","DOI":"10.1074\/jbc.M100747200","volume":"276","author":"C. Zhang","year":"2001","unstructured":"Zhang C, Cai Y, Adachi MT, et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem, 2001,276(38): 35867\u201335874","journal-title":"J Biol Chem"},{"issue":"13","key":"557_CR7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"C.J. Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 1995,274(13):1049\u20131057","journal-title":"JAMA"},{"issue":"16","key":"557_CR8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocystein Studies Collaboration.","year":"2002","unstructured":"Homocystein Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 2002,288(16):2015\u20132022","journal-title":"JAMA"},{"issue":"5","key":"557_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"J.W. Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J Jr, et al. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med, 1999,131(5): 363\u2013375","journal-title":"Ann Intern Med"},{"issue":"16","key":"557_CR10","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","volume":"288","author":"M. Klerk","year":"2002","unstructured":"Klerk M, Verhoef P, Clarke R, et al. MTHFR 677CT Polymorphism and risk of coronary heart disease: A meta-analysis. JAMA, 2002, 288(16):2023\u20132031.","journal-title":"JAMA"},{"issue":"7374","key":"557_CR11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"D.S. Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002,325(7374):1202\u20131206","journal-title":"BMJ"},{"issue":"6917","key":"557_CR12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P. Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature, 2002,420(6917):868\u2013874","journal-title":"Nature"},{"issue":"4","key":"557_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","volume":"252","author":"G.J. Blake","year":"2002","unstructured":"Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med, 2002,252(4): 283\u2013294","journal-title":"J Intern Med"},{"issue":"1","key":"557_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.0000133277.88655.00","volume":"110","author":"G. Engstr\u00f6m","year":"2004","unstructured":"Engstr\u00f6m G, Hedblad B, Stavenow L, et al. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: A Population-based prospective cohort study. Circulation, 2004,110(1):27\u201331","journal-title":"Circulation"},{"issue":"14","key":"557_CR15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J. Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004,350(14):1387\u20131397","journal-title":"N Engl J Med"},{"issue":"11","key":"557_CR16","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","volume":"32","author":"N.S. Rost","year":"2001","unstructured":"Rost NS, Wolf PA, Kase CS, et al. Plasma Concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The framingham study. Stroke, 2001,32(11):2575\u20132579","journal-title":"Stroke"},{"issue":"5","key":"557_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","volume":"97","author":"P.M. Ridker","year":"1998","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of c-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998,97(5): 425\u2013428","journal-title":"Circulation"},{"issue":"12","key":"557_CR18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"P.M. Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000,342(12):836\u2013843","journal-title":"N Engl J Med"},{"issue":"2","key":"557_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"W. Koenig","year":"1999","unstructured":"Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the monica (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992. Circulation, 1999,99(2):237\u2013242","journal-title":"Circulation"},{"issue":"3","key":"557_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.trsl.2007.02.006","volume":"150","author":"M.Y. Youssef","year":"2007","unstructured":"Youssef MY, Mojiminiyi OA, Abdella NA. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Transl Res, 2007,150(3): 158\u2013163","journal-title":"Transl Res"},{"issue":"3","key":"557_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00415-005-0647-9","volume":"252","author":"M.J. Bos","year":"2005","unstructured":"Bos MJ, van Goor ML, Koudstaal PJ, et al. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. J Neurol, 2005,252(3): 332\u2013337","journal-title":"J Neurol"},{"issue":"15","key":"557_CR22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E. Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med, 2006,354(15):1567\u20131577","journal-title":"N Engl J Med"},{"issue":"15","key":"557_CR23","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"NORVIT Investigators.","year":"2006","unstructured":"NORVIT Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med, 2006, 354(15):1578\u20131588","journal-title":"N Engl J Med"},{"issue":"7","key":"557_CR24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.STR.0000169934.96354.3a","volume":"36","author":"B. Guelpen Van","year":"2005","unstructured":"Van Guelpen B, Hultdin J, Johansson I, et al. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: A Prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke, 2005, 36(7):1426\u20131431","journal-title":"Stroke"},{"issue":"4","key":"557_CR25","first-page":"283","volume":"42","author":"J. Shao","year":"2003","unstructured":"Shao J, Yan J, Ye H, et al. Plasma homocysteine level associated with microalbuminuria in Chinese people. Chin J Internal Med, 2003,42(4):283\u2013284","journal-title":"Chin J Internal Med"},{"issue":"16","key":"557_CR26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"G.K. Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, Atherosclerosis, and coronary artery disease. N Engl J Med, 2005,352(16):1685\u20131695","journal-title":"N Engl J Med"},{"issue":"14","key":"557_CR27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"P.M. Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336(14):973\u2013979","journal-title":"N Engl J Med"},{"issue":"1","key":"557_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-006-8081-0","volume":"22","author":"J.L. Mega","year":"2006","unstructured":"Mega JL, Morrow DA, Cannon CP, et al. Cholesterol, c-reactive protein, and cerebrovascular events following intensive and moderate statin therapy, J Thromb Thrombolysis, 2006,22(1):71\u201376","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"557_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"P.M. Ridker","year":"2005","unstructured":"Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005,352(1):20\u201328","journal-title":"N Engl J Med"},{"issue":"5","key":"557_CR30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.STR.30.5.981","volume":"30","author":"K.W. Muir","year":"1999","unstructured":"Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke, 1999,30(5): 981\u2013985","journal-title":"Stroke"},{"issue":"4","key":"557_CR31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.STR.32.4.917","volume":"32","author":"M. Napoli Di","year":"2001","unstructured":"Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke, 2001,32(4):917\u2013924","journal-title":"Stroke"},{"issue":"1","key":"557_CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","volume":"36","author":"P. Dusitanond","year":"2005","unstructured":"Dusitanond P, Eikelboom JW, Hankey GJ, et al. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagul-ability in patients with previous transient ischemic attack or stroke: A randomized substudy of the vitatops trial. Stroke, 2005,36(1):144\u2013146","journal-title":"Stroke"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-010-0557-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-010-0557-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:15:06Z","timestamp":1559409306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-010-0557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s11596-010-0557-7","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}